L-酪胺酸 L-Tyrosine

INT-l-tyrosine-001 3 個適應症被研究
B 1 C 1 D 1

適應症與證據等級

法規與權威立場 (L4)

L4a · US FDA
立場:supportive
L-Tyrosine — CAS Reg. No. 60-18-4; 21 CFR 172.320; Permitted Technical Effects: FLAVORING AGENT OR ADJUVANT, NUTRIENT SUPPLEMENT; FEMA No. 3736; FEMA GRAS Publication No. 13; JECFA Flavor No. 1434.
來源 ↗
L4b · EU EFSA
立場:neutral
The Panel concludes that a cause and effect relationship has been established between the consumption of L-tyrosine in a protein adequate diet and contribution to normal synthesis of catecholamines / dopamine. No evidence has been provided that the protein supply in the diet of the European population is not sufficient to fulfil this function of the amino acid. For increased attention and contr…
來源 ↗
L4c · UK NHS
立場:not_addressed
unable to provide any recommendations about whether tyrosine supplementation should be introduced into routine clinical practice owing to no appropriate efficacy or safety outcome measures being evaluated
來源 ↗
L4d · TW TFDA / 衛福部
立場:neutral
目前得宣稱之保健功效共有13項:護肝、抗疲勞、調節血脂、調節血糖、免疫調節、骨質保健、牙齒保健、延緩衰老、促進鐵吸收、胃腸功能改善、輔助調節血壓、不易形成體脂肪、輔助調整過敏體質。
來源 ↗
L4e · WHO
立場:not_addressed

市場與行銷 (L10)

L10a · TW Market Channels
L-Tyrosine 500mg 120顆 NT$430
L10b · TW Legal Identity (TFDA)
限於補充食品中不足之營養素時使用
L10c · TW Community (PTT/Dcard/Mobile01)
出現心跳加快(安靜心跳100+) 全身無力,嗜睡